Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease - Trial NCT06250361
Access comprehensive clinical trial information for NCT06250361 through Pure Global AI's free database. This phase not specified trial is sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Timeline & Enrollment
N/A
Feb 15, 2024
Jun 15, 2025
Primary Outcome
Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.,Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.,Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.
Summary
The goal of this observational study is to determine the factors associated with a delayed
 diagnosis and/or an immediately complicated disease for CD patients.
 
 A questionnaire will be completed by the patients, each questionnaire has a patient section
 and a physician section.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06250361
Non-Device Trial